Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock)
US ˙ NasdaqGM ˙ US91864C1071

Introduction

This page provides a comprehensive analysis of the known insider trading history of Karen A Dawes. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Karen A Dawes has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:RGEN / Repligen Corporation Director 92,096
US:VACC / Vaccitech plc - ADR Director 1,700
US:04545LAA5 / Assertio Therapeutics Inc 5% 08/15/2024 CNV 144A Director 84,589
US:69329YAE4 / PDL BioPharma, Inc. Bond 2.875% Director 2,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Karen A Dawes. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock) - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock). This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2021-05-04 VACC DAWES KAREN A 1,700 17.0000 1,700 17.0000 28,900 13 17 0 0.00

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock) Insider Trades
Insider Sales BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock) - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock). A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BRNS / Barinthus Biotherapeutics plc - Depositary Receipt (Common Stock) Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Karen A Dawes as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-05-19 2025-05-15 4 RGEN REPLIGEN CORP
Common Stock
A - Award 973 92,096 1.07
2024-06-14 2024-06-14 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 2,953 88,170 3.47 67.71 199,948 5,969,991
2024-05-20 2024-05-16 4 RGEN REPLIGEN CORP
Common Stock
A - Award 803 88,170 0.92
2024-02-28 2024-02-27 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,000 87,367 -1.13 193.35 -193,350 16,892,409
2024-02-28 2024-02-27 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 4,626 88,367 5.52 42.07 194,616 3,717,600
2023-08-30 2023-08-29 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -850 83,741 -1.00 171.38 -145,673 14,351,533
2023-08-30 2023-08-29 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 7,392 84,591 9.58 18.12 133,943 1,532,789
2023-05-22 2023-05-18 4 RGEN REPLIGEN CORP
Common Stock
A - Award 798 77,199 1.04
2022-09-09 2022-09-09 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -775 76,401 -1.00 227.17 -176,057 17,356,015
2022-05-31 2022-05-26 4 RGEN REPLIGEN CORP
Common Stock
A - Award 644 77,176 0.84
2022-05-26 2022-05-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -742 76,532 -0.96 152.84 -113,407 11,697,151
2022-05-26 2022-05-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1,875 77,274 -2.37 152.14 -285,262 11,756,466
2022-05-26 2022-05-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1,845 79,149 -2.28 151.14 -278,853 11,962,580
2022-05-26 2022-05-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -7,677 80,994 -8.66 150.19 -1,153,009 12,164,489
2022-05-26 2022-05-25 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -2,576 88,671 -2.82 149.18 -384,288 13,227,940
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise 4,783 0 -100.00
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -14 91,247 -0.02 271.28 -3,798 24,753,486
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -255 91,261 -0.28 269.94 -68,835 24,634,994
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -349 91,516 -0.38 267.75 -93,445 24,503,409
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -486 91,865 -0.53 266.72 -129,626 24,502,233
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -488 92,351 -0.53 265.27 -129,452 24,497,950
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -336 92,839 -0.36 264.21 -88,775 24,528,992
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1,119 93,175 -1.19 263.23 -294,554 24,526,455
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1,038 94,294 -1.09 262.28 -272,247 24,731,430
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -236 95,332 -0.25 261.10 -61,620 24,891,185
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -462 95,568 -0.48 259.75 -120,004 24,823,788
2021-11-12 2021-11-10 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise -4,783 96,030 -4.74 26.12 -124,932 2,508,304
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -283 91,247 -0.31 306.49 -86,737 27,966,293
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -700 91,530 -0.76 305.91 -214,137 27,999,942
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -124 92,230 -0.13 304.23 -37,725 28,059,133
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -532 92,354 -0.57 303.48 -161,451 28,027,592
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -446 92,886 -0.48 301.97 -134,679 28,048,785
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -251 93,332 -0.27 301.20 -75,601 28,111,598
2021-11-04 2021-11-02 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -64 93,583 -0.07 299.02 -19,137 27,983,189
2021-09-15 2021-09-14 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -27 93,647 -0.03 295.82 -7,987 27,702,656
2021-09-15 2021-09-14 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -108 93,674 -0.12 295.02 -31,862 27,635,703
2021-09-15 2021-09-14 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -101 93,782 -0.11 294.06 -29,700 27,577,535
2021-09-15 2021-09-14 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -25 93,883 -0.03 292.34 -7,308 27,445,756
2021-09-15 2021-09-14 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -13 93,908 -0.01 290.02 -3,770 27,235,198
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise 3,459 0 -100.00
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -851 93,921 -0.90 285.44 -242,909 26,808,810
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -1,107 94,772 -1.15 284.64 -315,096 26,975,902
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -661 95,879 -0.68 283.56 -187,433 27,187,449
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -405 96,540 -0.42 282.53 -114,425 27,275,446
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -196 96,945 -0.20 281.68 -55,209 27,307,468
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -239 97,141 -0.25 280.27 -66,985 27,225,708
2021-09-02 2021-09-01 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise X -3,459 97,380 -3.43 38.76 -134,071 3,774,449
2021-08-19 2021-08-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X 40 93,921 0.04 262.31 10,492 24,636,418
2021-08-19 2021-08-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -78 93,961 -0.08 260.91 -20,351 24,515,365
2021-08-19 2021-08-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -388 94,039 -0.41 259.93 -100,853 24,443,557
2021-08-19 2021-08-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -634 94,427 -0.67 258.91 -164,149 24,448,095
2021-08-19 2021-08-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -302 95,061 -0.32 257.66 -77,813 24,493,417
2021-08-19 2021-08-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -194 95,363 -0.20 256.43 -49,747 24,453,934
2021-08-19 2021-08-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -2,231 95,557 -2.28 255.07 -569,061 24,373,724
2021-08-19 2021-08-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -8,580 97,788 -8.07 254.09 -2,180,092 24,846,953
2021-08-19 2021-08-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -4,665 106,368 -4.20 253.34 -1,181,831 26,947,269
2021-08-19 2021-08-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -920 111,033 -0.82 251.92 -231,766 27,971,433
2021-08-19 2021-08-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -924 111,953 -0.82 251.15 -232,063 28,116,996
2021-07-22 2021-07-13 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise 2,929 0 -100.00
2021-07-22 2021-07-13 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -5 117,462 0.00 204.02 -1,020 23,964,597
2021-07-22 2021-07-13 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -444 117,467 -0.38 203.09 -90,172 23,856,373
2021-07-22 2021-07-13 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -630 117,911 -0.53 202.29 -127,443 23,852,216
2021-07-22 2021-07-13 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -441 118,541 -0.37 201.27 -88,760 23,858,747
2021-07-22 2021-07-13 4/A RGEN REPLIGEN CORP
Common Stock
M - Exercise 2,929 118,982 2.52 41.19 120,646 4,900,869
2021-07-22 2021-07-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -614 112,877 -0.54 203.11 -124,710 22,926,447
2021-07-22 2021-07-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -2,877 113,491 -2.47 202.29 -581,988 22,958,094
2021-07-22 2021-07-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -806 116,368 -0.69 201.37 -162,304 23,433,024
2021-07-22 2021-07-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -288 117,174 -0.25 200.01 -57,603 23,435,972
2021-07-15 2021-07-13 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise 2,929 0 -100.00
2021-07-15 2021-07-13 4 RGEN REPLIGEN CORP
Common Stock
S - Sale 1,520 117,462 1.31 202.23 307,390 23,754,340
2021-07-15 2021-07-13 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 2,929 118,982 2.52 41.19 120,646 4,900,869
2021-05-17 2021-05-13 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 1,522 1,522
2021-05-17 2021-05-13 4 RGEN REPLIGEN CORP
Common Stock
A - Award 604 116,053 0.52
2021-05-13 2021-05-11 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -15,000 0 -100.00
2021-05-13 2021-05-11 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -285 115,449 -0.25 176.85 -50,402 20,417,156
2021-05-13 2021-05-11 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 15,000 115,734 14.89 3.22 48,300 372,663
2021-05-06 2021-05-04 4 VACC Vaccitech plc
Ordinary Shares
P - Purchase 1,700 1,700 17.00 28,900 28,900
2021-05-04 2021-04-29 4 VACC Vaccitech plc
Share Option (Right to Buy)
A - Award 34,328 34,328
2020-06-22 2020-06-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -2,568 100,734 -2.49 116.56 -299,326 11,741,555
2020-06-22 2020-06-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -8,217 103,302 -7.37 115.76 -951,200 11,958,240
2020-06-22 2020-06-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -5,243 111,519 -4.49 114.49 -600,271 12,767,810
2020-06-22 2020-06-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -2,677 116,762 -2.24 113.58 -304,054 13,261,828
2020-05-21 2020-05-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -182 119,439 -0.15 140.29 -25,533 16,756,097
2020-05-21 2020-05-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -282 119,621 -0.24 139.40 -39,311 16,675,167
2020-05-21 2020-05-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -43 119,903 -0.04 136.98 -5,890 16,424,313
2020-05-21 2020-05-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -10 119,946 -0.01 135.91 -1,359 16,301,861
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -80 119,956 -0.07 142.45 -11,396 17,087,732
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -77 120,036 -0.06 141.45 -10,892 16,979,092
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -180 120,113 -0.15 140.62 -25,312 16,890,290
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -122 120,293 -0.10 139.32 -16,997 16,759,221
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -269 120,415 -0.22 138.60 -37,283 16,689,519
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -160 120,684 -0.13 136.92 -21,907 16,524,053
2020-05-21 2020-05-18 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -712 120,844 -0.59 135.76 -96,661 16,405,781
2020-05-21 2020-05-13 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 1,761 1,761
2020-05-21 2020-05-13 4/A RGEN REPLIGEN CORP
Common Stock
A - Award 722 121,556 0.60
2020-05-21 2020-04-21 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -11,800 0 -100.00
2020-05-21 2020-04-21 4/A RGEN REPLIGEN CORP
Common Stock
M - Exercise 11,800 120,834 10.82 3.30 38,940 398,752
2020-05-21 2020-04-20 4/A RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -8,200 11,800 -41.00
2020-05-21 2020-04-20 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -8,998 109,034 -7.62 104.42 -939,571 11,385,330
2020-05-21 2020-04-20 4/A RGEN REPLIGEN CORP
Common Stock
S - Sale X -3,202 118,032 -2.64 104.98 -336,146 12,390,999
2020-05-21 2020-04-20 4/A RGEN REPLIGEN CORP
Common Stock
M - Exercise 8,200 121,234 7.25 3.30 27,060 400,072
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -80 119,956 -0.07 142.45 -11,396 17,087,732
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -77 120,036 -0.06 141.45 -10,892 16,979,092
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -180 120,113 -0.15 140.62 -25,312 16,890,290
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -122 120,293 -0.10 139.32 -16,997 16,759,221
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -269 120,415 -0.22 138.60 -37,283 16,689,519
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -160 120,684 -0.13 136.92 -21,907 16,524,053
2020-05-19 2020-05-18 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -712 120,844 -0.59 135.76 -96,661 16,405,781
2020-05-19 2020-05-13 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 1,761 1,761
2020-05-19 2020-05-13 4 RGEN REPLIGEN CORP
Common Stock
A - Award 722 121,556 0.60
2020-05-11 2020-05-08 4 ASRT Assertio Therapeutics, Inc
Common Stock
S - Sale X -15,834 84,589 -15.77 0.79 -12,531 66,944
2020-04-22 2020-04-21 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -11,800 0 -100.00
2020-04-22 2020-04-21 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 11,800 120,834 10.82 3.30 38,940 398,752
2020-04-22 2020-04-20 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -8,200 11,800 -41.00
2020-04-22 2020-04-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -8,998 109,034 -7.62 104.42 -939,571 11,385,330
2020-04-22 2020-04-20 4 RGEN REPLIGEN CORP
Common Stock
S - Sale X -3,202 118,032 -2.64 104.98 -336,146 12,390,999
2020-04-22 2020-04-20 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 8,200 121,234 7.25 3.30 27,060 400,072
2020-02-24 2020-02-21 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,849 113,034 -1.61 97.52 -180,314 11,023,076
2020-02-24 2020-02-21 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -906 114,883 -0.78 99.12 -89,803 11,387,203
2020-02-24 2020-02-21 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -945 115,789 -0.81 99.85 -94,358 11,561,532
2020-02-24 2020-02-21 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -300 116,734 -0.26 101.06 -30,318 11,797,138
2019-06-19 2019-06-17 4 RGEN REPLIGEN CORP
Stock Options (Right to Buy)
M - Exercise -20,000 0 -100.00
2019-06-19 2019-06-17 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -1,295 117,034 -1.09 77.35 -100,168 9,052,580
2019-06-19 2019-06-17 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 20,000 118,329 20.34 4.96 99,200 586,912
2019-06-14 2019-06-13 4 ASRT Assertio Therapeutics, Inc
Common Stock
S - Sale X -12,500 100,423 -11.07 3.18 -39,794 319,697
2019-05-17 2019-05-15 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 2,953 2,953
2019-05-17 2019-05-15 4 RGEN REPLIGEN CORP
Common Stock
A - Award 1,292 98,329 1.33
2019-05-09 2019-05-08 4 ASRT Assertio Therapeutics, Inc
Restricted Stock Units
M - Exercise -31,250 0 -100.00
2019-05-09 2019-05-08 4 ASRT Assertio Therapeutics, Inc
Common Stock
M - Exercise 31,250 112,923 38.26
2019-05-09 2019-05-07 4 ASRT Assertio Therapeutics, Inc
Common Stock
A - Award 39,584 81,673 94.05
2018-12-04 2018-12-03 4 ASRT Assertio Therapeutics, Inc
Stock Option
M - Exercise -15,000 0 -100.00
2018-12-04 2018-12-03 4 ASRT Assertio Therapeutics, Inc
Common Stock
S - Sale -8,421 42,089 -16.67 4.84 -40,725 203,547
2018-12-04 2018-12-03 4 ASRT Assertio Therapeutics, Inc
Common Stock
M - Exercise 15,000 50,510 42.24 1.49 22,350 75,260
2018-05-17 2018-05-16 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 4,626 4,626
2018-05-17 2018-05-16 4 RGEN REPLIGEN CORP
Common Stock
A - Award 2,080 97,037 2.19
2018-05-15 2018-05-11 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -20,000 0 -100.00
2018-05-15 2018-05-11 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -20,000 94,957 -17.40 41.80 -835,936 3,968,899
2018-05-15 2018-05-11 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 20,000 114,957 21.06 5.08 101,600 583,982
2018-05-10 2018-05-08 4 DEPO DEPOMED INC
Restricted Stock Units
A - Award 31,250 31,250
2017-08-16 2017-08-15 4 DEPO DEPOMED INC
Restricted Stock Units
A - Award 19,512 19,512
2017-05-22 2017-05-18 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 3,459 3,459
2017-05-22 2017-05-18 4 RGEN REPLIGEN CORP
Common Stock
A - Award 1,714 94,957 1.84
2017-03-22 2017-03-21 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -20,000 0 -100.00
2017-03-22 2017-03-21 4 RGEN REPLIGEN CORP
Common Stock
S - Sale -2,521 93,243 -2.63 34.12 -86,017 3,181,460
2017-03-22 2017-03-21 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 20,000 95,764 26.40 4.29 85,800 410,828
2016-07-15 2016-07-14 4 RGEN REPLIGEN CORP
Common Stock
A - Award 20,000 75,764 35.87
2016-06-28 2016-06-27 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
M - Exercise -15,000 0 -100.00
2016-06-28 2016-06-27 4 RGEN REPLIGEN CORP
Common Stock
F - Taxes -1,982 55,764 -3.43 23.46 -46,498 1,308,223
2016-06-28 2016-06-27 4 RGEN REPLIGEN CORP
Common Stock
M - Exercise 15,000 57,746 35.09 3.10 46,500 179,013
2016-05-20 2016-05-18 4 DEPO DEPOMED INC
Restricted Stock Units
A - Award 3,131 3,131
2016-05-20 2016-05-18 4 DEPO DEPOMED INC
Stock Options
A - Award 7,669 7,669
2016-05-13 2016-05-11 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 4,783 4,783
2016-05-13 2016-05-11 4 RGEN REPLIGEN CORP
Common Stock
A - Award 2,505 42,746 6.22
2016-05-13 2016-05-12 4 DEPO DEPOMED INC
Common Stock
F - Taxes -734 12,867 -5.40 17.52 -12,860 225,430
2015-12-03 2015-12-01 4 DEPO DEPOMED INC
Common Stock
F - Taxes -1,198 10,665 -10.10 19.00 -22,762 202,635
2015-11-12 2015-11-10 4 RGEN REPLIGEN CORP
Common Stock
A - Award 1,000 40,241 2.55 26.70 26,700 1,074,435
2015-05-26 2015-05-21 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 2,929 2,929
2015-05-26 2015-05-21 4 RGEN REPLIGEN CORP
Common Stock
A - Award 1,498 39,241 3.97
2015-05-13 2015-05-12 4 DEPO DEPOMED INC
Restricted Stock Unit
A - Award 2,936 2,936
2015-05-13 2015-05-12 4 DEPO DEPOMED INC
Stock Option
A - Award 7,857 7,857
2014-12-12 2014-12-01 4 DEPO DEPOMED INC
Restricted Stock Unit
A - Award 3,863 3,863
2014-12-12 2014-12-01 4 DEPO DEPOMED INC
Stock Option
A - Award 9,852 9,852
2014-05-19 2014-05-15 4 RGEN REPLIGEN CORP
Stock Option (Right to Buy)
A - Award 7,392 7,392
2014-05-19 2014-05-15 4 RGEN REPLIGEN CORP
Common Stock
A - Award 3,863 37,743 11.40
2013-12-12 2013-12-10 4 DEPO DEPOMED INC
Stock Option
A - Award 20,000 20,000
2013-06-21 2013-06-21 4 RGEN REPLIGEN CORP
Common Stock
P - Purchase 1,000 33,880 3.04 7.70 7,700 260,873
2013-05-16 2013-05-09 4 RGEN REPLIGEN CORP
Common Stock
A - Award 5,342 32,880 19.40
2013-03-06 2013-03-06 4 DEPO DEPOMED INC
Common Stock
P - Purchase 2,000 8,000 33.33 5.96 11,920 47,680
2012-12-06 2012-12-04 4 DEPO DEPOMED INC
Stock Option
A - Award 20,000 20,000
2012-06-20 2012-05-24 4 RGEN REPLIGEN CORP
Common Stock
A - Award 11,038 27,538 66.90
2006-09-05 2006-09-01 4 RGEN REPLIGEN CORP
Common Stock
P - Purchase 2,000 2,000 3.33 6,660 6,660
2005-06-27 2005-05-24 4/A PDLI PROTEIN DESIGN LABS INC/DE
Common Stock
M - Exercise 0 2,000 0.00 13.55 27,100
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)